Central Finding
Every major legislative and regulatory effort to restrict asbestos in the United States over the past 50 years has been delayed, weakened, or overturned. Lobbying disclosure records and litigation documents demonstrate a sustained, funded industry campaign to block meaningful asbestos regulation — even as manufacturers' own internal records showed conclusive evidence of the health risks their products posed.
The Regulatory Timeline
Why the US Has Not Banned Asbestos
The United States is one of the few industrialized nations without a comprehensive asbestos ban. More than 55 countries — including all EU members, the UK, Canada, Australia, and Japan — have banned asbestos. Russia and China remain the world's primary producers.
Four structural factors have enabled asbestos to remain legal despite decades of documented health evidence:
Structural Factors
1. The Corrosion Proof Fittings precedent (1991). The Fifth Circuit's interpretation of TSCA made it practically impossible for EPA to ban established chemicals without surviving an almost unachievable cost-benefit analysis. This interpretation stood for 25 years.
2. Ongoing asbestos industry lobbying. Though US asbestos mining ended in 2002, manufacturers of asbestos-containing products continue to fund lobbying against a comprehensive ban.
3. Congressional inaction on health-based chemical regulation. TSCA was not meaningfully reformed for 40 years. During this period the statute made regulatory action on established chemicals essentially impossible.
4. Industry-funded scientific uncertainty. Asbestos manufacturers funded research designed to create doubt about the dose-response relationship between asbestos and cancer — particularly the so-called "chrysotile defense" arguing that chrysotile poses less risk than amphibole forms. Independent medical consensus rejects this distinction as a basis for different regulatory treatment.